Resources and Products
Explore topics by clicking on one of the bubbles below.
- Bloodborne Pathogens
- Candida auris (C.auris)
- Carbapenem-Resistant Enterobacterales (CRE)
- Clostridioides difficile (C.diff)
- Data Management
- Dialysis Settings
- Drug Diversion
- Epidemic Keratoconjunctivitis (EKC)
- Medical Products
- Nontuberculous Mycobacteria (NTM)
- Patient Notification
- Spotlight Series
- Viral Hepatitis
- Water Associated Organisms
Medical products, such as devices, drugs, and biologics, play crucial roles in medical diagnosis and treatment. They also present risks. Patient infections can occur when a medical product is contaminated during manufacturing, compounding, storage, preparation, use, or misuse. Outbreaks can occur when groups of patients are exposed to contaminated medical products either in a single facility (as a result of mishandling by healthcare personnel) or across multiple facilities (for example, when a product is contaminated at the point of manufacture prior to distribution).
- CORHA’s Potential Medical Product-Related Infection/Outbreak: Assessment Questions presents information and questions for use by health departments, healthcare facilities, and other parties involved in investigating possible medical product involvement in a cluster of infections or outbreak
Resources related to medical product outbreaks:
- CDC’s Outbreak Investigations in Healthcare Settings website, which contains examples of healthcare outbreaks that were caused by distributed medical products including contaminated stem cell products, saline flush, and heater-cooler devices
- CORHA’s Injection Safety and Drug Diversion topic pages
- The FDA MedWatch form is located here: MedWatch Online Voluntary Reporting Form (fda.gov). Maintain a low threshold for reporting observed or suspected adverse events for human medical products.
CORHA Principles and Practices for Healthcare Outbreak Response
CORHA Potential Medical Product-Related Infection/Outbreak: Assessment Questions